HEPES is Radioprotective
In our original work in 1996 we described the apparent radioprotective effects of HEPES. Noting that HEPES as a biological response modifier (BRM) was apparently radioprotective in patients with radiation implant exposure.
There was further validation by Sasson https://lnkd.in/dbKdafs in 2010.
In 1996 we noted the radioprotective effects (and reduction in radiation side effects in cancer patients). We noted this in our patents and published articles (Cancer Biotherapy and Radiation Pharmaceuticals). We also demonstrated the ability of HEPES to induce extramedullary hematapoiesis.
A confirming study (as a radioprotectant) was reported in the Journal of Radioanalytical and Nuclear Chemistry (Sasoon et al). There have been several articles (some very recent) confirming the effects we noted years ago. (coronary reperfusion, effects on prions, effects related to Alzheimer’s, etc)
We noticed agencies in Japan following the accident at Fukushima Daiichi.
Now there is the serious nuclear accident in the far north in Russia.
This possible radioprotective effects of HEPES should not be ignored.